Search - tctmd.com

Displaying 661 - 680 of 740

Sort: Relevancy | Date

Presentation TCT 2016

Follow-up Evaluation After LAA Closure

Presenter: David R. Holmes Jr., Jacqueline Saw, Bushra S Rana

November 01, 2016

Presentation TCT 2016

Pivotal Trial Design Considerations: Noninferiority vs Superiority, Device, Control Arm Anticoagulation Durations, NOAC Considerations and More Industry and Clinician Perspectives

Presenter: Aaron V. Kaplan, Rachel Neubrander, Brian K. Whisenant

November 01, 2016

Presentation TCT 2016

Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS?

Presenter: Martin W. Bergmann, Samir R. Kapadia, Vivek Y. Reddy

November 01, 2016

Presentation TCT 2016

Trial Designs For LAA Closure: Potential Regulatory Pathways and Unanswered Questions What FDA Would Like to See

Presenter: Aaron V. Kaplan, Rachel Neubrander, Katherine Wallon

November 01, 2016

Presentation TCT 2016

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Presenter: Martin W. Bergmann, Samir R. Kapadia, Harvey D. White

November 01, 2016

Presentation TCT 2016

Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping

Presenter: Martin W. Bergmann, Samir R. Kapadia, Jason H. Rogers

November 01, 2016

Presentation TCT 2016

Special Tips and Tricks for LAA Closure Using the Lariat

Presenter: Krzysztof Bartus, Randall J. Lee

November 01, 2016

Presentation TCT 2016

Special Tips and Tricks for LAA Closure Using the Lifetech LAA Occluder

Presenter: Krzysztof Bartus, Yat-Yin Lam

November 01, 2016

Presentation TCT 2016

Is LAA Closure an Alternative to Triple Therapy for all Patients or Those at High Bleeding Risk? Current Dataset

Presenter: Martin W. Bergmann, Samir R. Kapadia, Brian K. Whisenant

November 01, 2016

Presentation TCT 2016

Special Tips and Tricks for LAA Closure Using the Cardia LAA Occluder

Presenter: Krzysztof Bartus, Josep Rodés-Cabau

November 01, 2016

Presentation TCT 2016

Why Triple Therapy? Rationale and Potential Role for LAA Closure in the PCI Patient

Presenter: Martin W. Bergmann, Samir R. Kapadia, Ashish Pershad

November 01, 2016

Presentation TCT 2016

Special Tips and Tricks for LAA Closure Using the Occlutech LAA Occluder

Presenter: Krzysztof Bartus, Eustaquio Maria Onorato

November 01, 2016

Presentation TCT 2016

Special Tips and Tricks for LAA Closure Using the WaveCrest LAA Occluder

Presenter: Krzysztof Bartus, Vivek Y. Reddy

November 01, 2016

Presentation TCT 2016

Special Tips and Tricks for LAA Closure Using the ACP/Amulet LAA Occluder

Presenter: Krzysztof Bartus, Jai-Wun Park

November 01, 2016

Presentation TCT 2016

Special Tips and Tricks for LAA Closure Using the Watchman LAA Occluder

Presenter: Krzysztof Bartus, Saibal Kar

November 01, 2016

Presentation TCT 2016

General Principles of LAA Closure

Presenter: Krzysztof Bartus, Apostolos Tzikas

November 01, 2016

Presentation TCT 2016

Pericardial Access Tips and Tricks

Presenter: Maurice Buchbinder, Saibal Kar, Issam D. Moussa

November 01, 2016

Presentation TCT 2016

How to Perform Transseptal Puncture Safely and Effectively

Presenter: Maurice Buchbinder, Saibal Kar, Stefan C. Bertog

November 01, 2016

Presentation TCT 2016

Venous Access Specifics: Puncture, Sheath Introduction, Traversing the IVC, and Puncture Site Closure

Presenter: Maurice Buchbinder, Saibal Kar, Sameer Gafoor

November 01, 2016

Presentation TCT 2016

The Potential for 3D Printing and Imaging for LAA Closure

Presenter: Samir R. Kapadia, Apostolos Tzikas, James K. Min

November 01, 2016

Advertisement

Follow-up Evaluation After LAA Closure

Pivotal Trial Design Considerations: Noninferiority vs Superiority, Device, Control Arm Anticoagulation Durations, NOAC Considerations and More Industry and Clinician Perspectives

Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS?

Trial Designs For LAA Closure: Potential Regulatory Pathways and Unanswered Questions What FDA Would Like to See

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping

Special Tips and Tricks for LAA Closure Using the Lariat

Special Tips and Tricks for LAA Closure Using the Lifetech LAA Occluder

Is LAA Closure an Alternative to Triple Therapy for all Patients or Those at High Bleeding Risk? Current Dataset

Special Tips and Tricks for LAA Closure Using the Cardia LAA Occluder

Why Triple Therapy? Rationale and Potential Role for LAA Closure in the PCI Patient

Special Tips and Tricks for LAA Closure Using the Occlutech LAA Occluder

Special Tips and Tricks for LAA Closure Using the WaveCrest LAA Occluder

Special Tips and Tricks for LAA Closure Using the ACP/Amulet LAA Occluder

Special Tips and Tricks for LAA Closure Using the Watchman LAA Occluder

General Principles of LAA Closure

Pericardial Access Tips and Tricks

How to Perform Transseptal Puncture Safely and Effectively

Venous Access Specifics: Puncture, Sheath Introduction, Traversing the IVC, and Puncture Site Closure

The Potential for 3D Printing and Imaging for LAA Closure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content